Before revision:  To study the cascades  molecular events underlying the poor prognosis that are due to limited treatment options for advance disease and resistance to conventional therapies in UCC, transcriptomics technology (RNA-Seq), a method of analysing the RNA content of a sample using the modern high-throughput sequencing platforms has been employed to address these limitations .
After revision:  To study the cascades molecular events underlying the poor prognosis that are due to limited treatment options for advance disease and resistance to conventional therapies in UCC, transcriptomics technology (RNA-Seq), a method of analysing the RNA content of a sample using the modern high-throughput sequencing platforms has been employed .